Tribenzyltin carboxylates as anticancer drug candidates: Effect on the cytotoxicity, motility and invasiveness of breast cancer cell lines

被引:28
作者
Anasamy, Theebaa [1 ]
Thy, Chun Keng [2 ]
Lo, Kong Mun [2 ,3 ]
Chee, Chin Fei [2 ]
Yeap, Swee Keong [4 ]
Kamalidehghan, Behnam [5 ,6 ]
Chung, Lip Yong [1 ]
机构
[1] Univ Malaya, Dept Pharm, Fac Med, Kuala Lumpur 50603, Malaysia
[2] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 50603, Malaysia
[3] Sunway Univ, Res Ctr Crystalline Mat, Petaling Jaya 47500, Selangor Darul, Malaysia
[4] Univ Putra Malaysia, Inst Biosci, Serdang 43400, Selangor Darul, Malaysia
[5] Shahid Beheshti Univ Med Sci, Sch Med, Dept Med Genet, Tehran 1983963113, Iran
[6] NIGEB, Med Genet Dept, Tehran 1497716316, Iran
关键词
Organotin complexes; Tribenzyltin carboxylates; Anticancer; Antimotility; Apoptosis; Breast cancer; PROTEASOME INHIBITORS; IN-VITRO; PYRROLIDINE DITHIOCARBAMATE; CASPASE ACTIVATION; ANTITUMOR-ACTIVITY; APOPTOSIS; COMPLEXES; TUMOR; FLUORINE; ASSAY;
D O I
10.1016/j.ejmech.2016.09.061
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This study seeks to investigate the relationship between the structural modification and bioactivity of a series of tribenzyltin complexes with different ligands and substitutions. Complexation with the N,N-diisopropylcarbamothioylsulfanylacetate or isonicotinate ligands enhanced the anticancer properties of tribenzyltin compounds via delayed cancer cell-cycle progression, caspase-dependent apoptosis induction, and significant reduction in cell motility, migration and invasion. Halogenation of the benzyl ring improved the anticancer effects of the tribenzyltin compounds with the N,N-diisopropylcarbamothioylsulfanylacetate ligand. These compounds also demonstrated far greater anticancer effects and selectivity than cisplatin and doxorubicin, which provides a rationale for their further development as anticancer agents. (C) 2016 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:770 / 783
页数:14
相关论文
共 78 条
[1]   Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells [J].
Adsule, Shreelekha ;
Barve, Vivek ;
Chen, Di ;
Ahmed, Fakhara ;
Dou, Q. Ping ;
Padhye, Subhash ;
Sarkar, Fazlul H. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) :7242-7246
[2]   Organometallic compounds in oncology: implications of novel organotins as antitumor agents [J].
Alama, Angela ;
Tasso, Bruno ;
Novelli, Federica ;
Sparatore, Fabio .
DRUG DISCOVERY TODAY, 2009, 14 (9-10) :500-508
[3]   Copper conjugates of nimesulide Schiff bases targeting VEGF, COX and Bcl-2 in pancreatic cancer cells [J].
Ambike, Vinita ;
Adsule, Shreelekha ;
Ahmed, Fakhara ;
Wang, Zhiwei ;
Afrasiabi, Zahra ;
Sinn, Ekkehard ;
Sarkar, Fazlul ;
Padhye, Subhash .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2007, 101 (10) :1517-1524
[4]   Organo-tin antitumor compounds: Their present status in drug development and future perspectives [J].
Arjmand, Farukh ;
Parveen, Sabiha ;
Tabassum, Sartaj ;
Pettinari, Claudio .
INORGANICA CHIMICA ACTA, 2014, 423 :26-37
[5]  
Awang N, 2012, Pak J Biol Sci, V15, P833
[6]   Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes [J].
Baul, Tushar S. Basu ;
Paul, Anup ;
Pellerito, Lorenzo ;
Scopelliti, Michelangelo ;
Singh, Palwinder ;
Verma, Pooja ;
de Vos, Dick .
INVESTIGATIONAL NEW DRUGS, 2010, 28 (05) :587-599
[7]   MOLECULAR-STRUCTURE OF THE HALOGENATED ANTICANCER DRUG IODODOXORUBICIN COMPLEXED WITH D(TGTACA) AND D(CGATCG) [J].
BERGER, I ;
SU, L ;
SPITZNER, JR ;
KANG, C ;
BURKE, TG ;
RICH, A .
NUCLEIC ACIDS RESEARCH, 1995, 23 (21) :4488-4494
[8]   Tumorigenesis and the angiogenic switch [J].
Bergers, G ;
Benjamin, LE .
NATURE REVIEWS CANCER, 2003, 3 (06) :401-410
[9]   PYRROLIDINE DITHIOCARBAMATE, A POTENT INHIBITOR OF NUCLEAR FACTOR KAPPA-B (NF-KAPPA-B) ACTIVATION, PREVENTS APOPTOSIS IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS AND THYMOCYTES [J].
BESSHO, R ;
MATSUBARA, K ;
KUBOTA, M ;
KUWAKADO, K ;
HIROTA, H ;
WAKAZONO, Y ;
LIN, YW ;
OKUDA, A ;
KAWAI, M ;
NISHIKOMORI, R ;
HEIKE, T .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) :1883-1889
[10]   Opinion - The role of apoptosis in cancer development and treatment response [J].
Brown, JM ;
Attardi, LD .
NATURE REVIEWS CANCER, 2005, 5 (03) :231-237